Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Esperion Therapeutics stock
Learn how to easily invest in Esperion Therapeutics stock.
Esperion Therapeutics Inc is a drug manufacturers-specialty & generic business based in the US. Esperion Therapeutics shares (ESPR) are listed on the NASDAQ and all prices are listed in US Dollars. Esperion Therapeutics employs 218 staff and has a trailing 12-month revenue of around $67.5 million.
How to buy shares in Esperion Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ESPR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Esperion Therapeutics stock price (NASDAQ: ESPR)Use our graph to track the performance of ESPR stocks over time.
Esperion Therapeutics shares at a glance
|Latest market close||$6.70|
|52-week range||$3.28 - $13.14|
|50-day moving average||$6.91|
|200-day moving average||$5.55|
|Wall St. target price||$10.70|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-6.24|
Buy Esperion Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Esperion Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Esperion Therapeutics price performance over time
|1 week (2022-09-23)||6.7|
|1 month (2022-09-02)||-14.76%|
|3 months (2022-07-01)||3.88%|
|6 months (2022-03-29)||35.08%|
|1 year (2021-10-01)||-43.79%|
|2 years (2020-10-02)||-80.40%|
|3 years (2019-10-02)||36.5|
|5 years (2017-10-02)||52.22|
Esperion Therapeutics financials
|Revenue TTM||$67.5 million|
|Gross profit TTM||$-41,745,000|
|Return on assets TTM||-41.38%|
|Return on equity TTM||-260.79%|
|Market capitalisation||$445.9 million|
TTM: trailing 12 months
Esperion Therapeutics share dividends
We're not expecting Esperion Therapeutics to pay a dividend over the next 12 months.
Have Esperion Therapeutics's shares ever split?
Esperion Therapeutics's shares were split on a 1:6 basis on 11 June 2013. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Esperion Therapeutics shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Esperion Therapeutics shares which in turn could have impacted Esperion Therapeutics's share price.
Esperion Therapeutics share price volatility
Over the last 12 months, Esperion Therapeutics's shares have ranged in value from as little as $3.28 up to $13.14. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Esperion Therapeutics's is 0.165. This would suggest that Esperion Therapeutics's shares are less volatile than average (for this exchange).
Esperion Therapeutics overview
Esperion Therapeutics, Inc. , a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. .
Esperion Therapeutics in the news
Strength Seen in Esperion Therapeutics (ESPR): Can Its 5.7% Jump Turn into More Strength?
Why Is United Therapeutics (UTHR) Up 2.1% Since Last Earnings Report?
Frequently asked questionsWhat percentage of Esperion Therapeutics is owned by insiders or institutions?
Currently 0.821% of Esperion Therapeutics shares are held by insiders and 87.133% by institutions. How many people work for Esperion Therapeutics?
Latest data suggests 218 work at Esperion Therapeutics. When does the fiscal year end for Esperion Therapeutics?
Esperion Therapeutics's fiscal year ends in December. Where is Esperion Therapeutics based?
Esperion Therapeutics's address is: 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108 What is Esperion Therapeutics's ISIN number?
Esperion Therapeutics's international securities identification number is: US29664W1053 What is Esperion Therapeutics's CUSIP number?
Esperion Therapeutics's Committee on Uniform Securities Identification Procedures number is: 16934W106
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert